Efficacy
PD
DISEASE
The median number of CapeOX treatment cycles was 6.0 in both groups. The median actual dose intensities in the original-dose and reduced-dose groups were 5732.8 mg/mThe overall response rate (ORR) of patients with target lesions was 60.3% (95% CI 48.1–71.6%; complete response, Waterfall plot showing the best overall response for each patient. CR, complete response; PR, partial response; SD, stable disease; and PD, progressive diseaseThe median duration of follow-up for all patients was 40.2 months. The median OS was 12.9 (95% CI 11.6–14.8) months, and the 1-year OS rate was 56.4% (95% CI 46.2–65.3%; Fig. Kaplan–Meier overall survival. Kaplan–Meier progression-free survival. 